Gam-COVID-Vac phase 3 trial results: 91·6% efficacy and well tolerated
by from Hacker News on (#5DMXX)
External Content
| Source | RSS or Atom Feed |
| Feed Location | http://news.ycombinator.com/rss |
| Feed Title | Hacker News |
| Feed Link | https://news.ycombinator.com/ |
| Reply | 0 comments |